These findings concur with our results in BI6015-para-treated cancer cell lines, showing downregulation of FZD2 and FZD8, and CSNK1A1 upregulation (Fig. 5c), also supporting our survival analysis result (Fig. 6). This evidence concerns the gene FZD2 and cancer.